NIVF
NewGenIvf Group Limited Class A Ordinary Shares
NASDAQ: NIVF · HEALTHCARE · MEDICAL CARE FACILITIES
$1.15
-18.56% today
Updated 2026-06-04
Market cap
$1.77M
P/E ratio
0.02
P/S ratio
0.38x
EPS (TTM)
$36.48
Dividend yield
—
52W range
$0 – $618
Volume
2.9M
WallStSmart proprietary scores
58
out of 100
Grade: C+
Hold
Investment rating
4.0
Growth
C9.0
Quality
A+6.0
Profitability
B6.7
Valuation
B4/9
Piotroski F-Score
Moderate
4.1
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$14.12
+1127.83%
12-Month target
$3,305.41
+287326.96%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Altman Z 4.07 — safe zone
+ Profit margin 209.00% — above average
+ ROE 79.40% — strong efficiency
+ Revenue growth 11.90% QoQ
+ Debt/equity 0.18x — low leverage
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $5.94M | $5.14M | $5.43M | $4.73M | $4.73M |
| Net income | $458667.00 | $-690851.00 | $-525000.00 | $9.88M | $-7.67M |
| EPS | — | — | — | — | $36.48 |
| Free cash flow | $-621575.00 | $-927204.00 | $-8.32M | $-16.68M | — |
| Profit margin | 7.72% | -13.45% | -9.66% | 209.02% | 209.00% |
Peer comparison
Smart narrative
NewGenIvf Group Limited Class A Ordinary Shares trades at $1.15. representing a P/E of 0.02x trailing earnings. Our Smart Value Score of 58/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 4.07, it sits in the safe zone. TTM revenue stands at $4.73M. with profit margins at 209.00%.
Frequently asked questions
What is NewGenIvf Group Limited Class A Ordinary Shares's stock price?
NewGenIvf Group Limited Class A Ordinary Shares (NIVF) trades at $1.15, on a P/E of 0.0x and a P/S of 0.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is NewGenIvf Group Limited Class A Ordinary Shares overvalued?
NewGenIvf Group Limited Class A Ordinary Shares carries a Smart Value Score of 58/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of NewGenIvf Group Limited Class A Ordinary Shares (NIVF)?
The 12-month analyst consensus target is $14.12, about 1127.8% above the current $1.15. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is NewGenIvf Group Limited Class A Ordinary Shares's revenue?
NewGenIvf Group Limited Class A Ordinary Shares's trailing twelve-month revenue is $4.73M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
NewGenIvf Group Limited Class A Ordinary Shares's Altman Z-Score is 4.07, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.38x
ROE79.40%
Beta-0.08
50D MA$1.61
200D MA$33.51
Shares out0.00B
Float0.00B
Short ratio—
Avg volume2.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—